|
|
|
This is the preliminary program for the 2007 Joint Statistical
Meetings in Salt Lake City, Utah.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2007 Program page |
= Applied Session,
= Theme Session,
= Presenter
484
|
Thu, 8/2/07, 8:30 AM - 10:20 AM | CC-355 F |
| Statistical Validation of Surrogate Endpoints - Invited - Papers | ||
|
Biopharmaceutical Section, Biometrics Section, Committee on Applied Statisticians, WNAR |
||
| Organizer(s): Peiqi Chen, Eli Lilly and Company | ||
| Chair(s): Stacy Lindborg, Eli Lilly and Company | ||
| 8:35 AM |
Unified Approaches for Surrogate Marker Evaluation from Multiple Randomized Clinical Trials —  Geert Molenberghs, Hasselt University
|
|
| 9:00 AM |
Evaluating and Using Surrogate Endpoints in Clinical Trials: A Bayesian Approach — Mary K. Cowles, The University of Iowa; Qian Shi, The University of Iowa
|
|
| 9:25 AM |
Surrogate Endpoint Validation: Statistical Elegance versus Clinical Relevance — Daniel J. Sargent, Mayo Clinic
|
|
| 9:50 AM | Disc: Sue-Jane Wang, Food and Drug Administration | |
| 10:10 AM | Floor Discussion | |
|
JSM 2007
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |